Humira Kit
Product Images NDC 50090-4487

55 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 55 technical images submitted to the FDA as part of the official labeling for Humira (NDC 50090-4487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Title: Fig1-acr20 (Humira 01)

Title: Fig1-acr20 (Humira 01)
A line graph comparing the percent of ACR20 responders over time (weeks) between two groups: one receiving 40 mg every other week and a placebo group. The 40 mg group shows a higher and sustained response rate across approximately 48 weeks, while the placebo group's response remains lower and more variable.*
FDA Label Image

Title: Fig2-asas20-response (Humira 02)

Title: Fig2-asas20-response (Humira 02)
A line graph showing the percentage of ASAS 20 response over time in weeks comparing HUMIRA (adalimumab) with placebo. The x-axis represents time in weeks (0 to 24), and the y-axis shows the percentage of response (0 to 70%). Two lines plot the data: one solid line for HUMIRA and one dashed line for placebo, with the HUMIRA group showing a higher percentage response over the study period.*
FDA Label Image

Title: Km-graph-fig3-study-uv-i (Humira 03)

Title: Km-graph-fig3-study-uv-i (Humira 03)
A line graph showing treatment failure rates over time (in months) comparing HUMIRA and placebo treatments. The y-axis represents treatment failure rate percentage, and the x-axis represents time in months. The graph includes numerical data points for both treatments at various time intervals.*
FDA Label Image

Title: Uveitis-km-fig3-part2 (Humira 04)

Title: Uveitis-km-fig3-part2 (Humira 04)
A line graph showing treatment failure rate over time (months) comparing HUMIRA to placebo. The x-axis represents time in months up to 20 months, and the y-axis represents treatment failure rate percentage. Two lines depict the failure rates for placebo and HUMIRA treatments, with HUMIRA showing a lower failure rate over time.*
FDA Label Image

Title: Km-peds-uv (Humira 05)

Title: Km-peds-uv (Humira 05)
A Kaplan-Meier curve displaying the probability of failing treatment over time in weeks. The graph compares two groups: one treated with HUMIRA and one with a placebo. The y-axis represents the probability of treatment failure, and the x-axis shows time in weeks. Sample sizes at risk for both groups are listed below the graph at several time points.*
FDA Label Image

Title: Fig-a-pen-image (Humira 06)

Title: Fig-a-pen-image (Humira 06)
An instructional diagram showing parts of a HUMIRA (adalimumab) injection pen. Labeled components include a plum-colored cap (Cap #2), plum-colored activator button, window, white needle sleeve, and gray cap (Cap #1). The diagram visually guides identification and assembly of the pen device parts in the HUMIRA kit.*
FDA Label Image

Title: Fig-b-pen-with-window (Humira 07)

Title: Fig-b-pen-with-window (Humira 07)
An instructional illustration showing a hand holding a pen-like injection device. A close-up inset highlights a viewing window on the device with a marked fill line, indicating fluid level inside the device.*
FDA Label Image

Title: Humira-fig-c-hand-with-pen-b (Humira 08)

Title: Humira-fig-c-hand-with-pen-b (Humira 08)
An illustration shows a hand holding a HUMIRA kit device, depicting the proper grip with the thumb pressing on the red area at the bottom of the pen-shaped injector.*
FDA Label Image

Title: Injectable Areas (Humira 09)

Title: Injectable Areas (Humira 09)
An instructional diagram showing the recommended injectable areas on the human body for administering a medication. Highlighted regions include the abdomen and the front of both thighs with arrows pointing to these injection sites.*
FDA Label Image

Title: Humira-pen-fig-e-hand-hold-gray-cap-b (Humira 0a)

Title: Humira-pen-fig-e-hand-hold-gray-cap-b (Humira 0a)
An illustration showing a hand holding a Humira (Adalimumab) pen injector, a component of the Humira KIT. The pen is partially transparent at the bottom, revealing internal parts, with an arrow indicating an action step, likely related to activation or injection.*
FDA Label Image

Title: Humira-pen-fig-f-gray-cap-removal-b (Humira 0b)

Title: Humira-pen-fig-f-gray-cap-removal-b (Humira 0b)
An instructional illustration showing hands removing a cap from a pen-style injector device. The device has a red base and an upward-pointing arrow indicating the direction to remove the cap.*
FDA Label Image

Title: Humira-pen-fig-g-plum-cap-removal-b (Humira 0c)

Title: Humira-pen-fig-g-plum-cap-removal-b (Humira 0c)
An instructional illustration showing a hand holding a pen-like injection device with a pink cap, featuring arrows and markings on the device body. This image is likely part of usage directions for the HUMIRA Adalimumab kit by A-S Medication Solutions.*
FDA Label Image

Title: Squeezed Skin (Humira 0d)

Title: Squeezed Skin (Humira 0d)
An instructional illustration showing a hand applying pressure or holding a rounded object, possibly a joint, with the thumb positioned on top while the other fingers wrap around from below. The image is in grayscale and appears to demonstrate a step or technique related to physical care or examination.*
FDA Label Image

Title: Ifu-40mg-0-8ml-figj-pen-angle (Humira 0e)

Title: Ifu-40mg-0-8ml-figj-pen-angle (Humira 0e)
An instructional illustration showing a person holding a syringe device at a 90-degree angle to the thigh. Both hands are shown, one holding the device and the other steadying the injection site on the upper leg. The image likely demonstrates how to properly position the injection for HUMIRA (Adalimumab) kit use.*
FDA Label Image

Title: Pen Ten Second Injection (Humira 0f)

Title: Pen Ten Second Injection (Humira 0f)
An instructional illustration showing a person administering a subcutaneous injection using a prefilled pen or syringe. The image includes a stopwatch indicating a 10-second wait time and a "click" sound effect, suggesting the injection device activates or completes with an audible click.*
FDA Label Image

Title: Fig-l-yellow-indicator (Humira 10)

Title: Fig-l-yellow-indicator (Humira 10)
An illustration showing a pen-style device with a red cap and a detailed close-up of the device's yellow indicator. The image highlights the yellow indicator feature on the device, with arrows and a label pointing to it.*
FDA Label Image

Title: Pen White Needle Sleeve (Humira 11)

Title: Pen White Needle Sleeve (Humira 11)
An instructional diagram showing a section of a medical device component with a white needle sleeve and a yellow window marker. Arrows and labels point to these parts, indicating their location on the device, likely part of the HUMIRA kit.*
FDA Label Image

Title: Ifu-pen-fign-sharp-cont (Humira 12)

Title: Ifu-pen-fign-sharp-cont (Humira 12)
An instructional illustration showing a hand disposing of a syringe or pen device into a sharps container. The image is related to safe disposal practices, likely for a medication kit such as HUMIRA (Adalimumab) Kit.*
FDA Label Image

Title: Fig-a-ifu-40mg-pen (Humira 13)

Title: Fig-a-ifu-40mg-pen (Humira 13)
An illustration diagram of the HUMIRA single-dose pen showing labeled components including a gray cap #1 covering the needle, a white needle sleeve with a white arrow, an inspection window on the pen body, a plum activator button, and a plum-colored cap #2. The diagram visually breaks down the pen into parts for instructional purposes.*
FDA Label Image

Title: Step1-pen-ifu-40mg (Humira 14)

Title: Step1-pen-ifu-40mg (Humira 14)
Instructional illustration showing Step 1 of a process, depicting a hand reaching towards a kit or box containing multiple items, possibly related to the HUMIRA Adalimumab kit by A-S Medication Solutions.*
FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step2 (Humira 15)

Title: Ifu-40mg-0-4ml-pen-step2 (Humira 15)
An instructional illustration labeled "STEP 2" showing a disposal container for sharps, a close-up of a capped syringe needle, and kit components including a prefilled syringe with a red cap, an antiseptic wipe, and a small device or accessory. This step likely demonstrates safe disposal or preparation related to injection.*
FDA Label Image

Title: Humira Mai Ifu Resize Step3 (Humira 16)

Title: Humira Mai Ifu Resize Step3 (Humira 16)
An instructional illustration labeled 'STEP 3' showing preferred injectable areas for a drug kit. It highlights the abdomen and front thigh regions as suitable injection sites, with arrows indicating specific spots on each area. The image is designed to guide proper administration of the medication.*
FDA Label Image

Title: Humira Mai Ifu Resize1 Step4 (Humira 17)

Title: Humira Mai Ifu Resize1 Step4 (Humira 17)
An illustration showing Step 4 in the use of a medication pen, with a hand holding the pen and a close-up inset highlighting the activation or injection mechanism. The image is part of a step-by-step instructional guide for HUMIRA (Adalimumab) Kit usage.*
FDA Label Image

Title: Humira-mai-ifu-resize1-step5 (Humira 18)

Title: Humira-mai-ifu-resize1-step5 (Humira 18)
An instructional illustration showing Step 5 of a process involving a kit. It depicts a pen-like device with an arrow pointing to the removal of a cap labeled CAP #1, and another arrow pointing to CAP #2. The illustration is likely part of a multi-step usage guide for the HUMIRA (Adalimumab) kit by A-S Medication Solutions.*
FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step6 (Humira 19)

Title: Ifu-40mg-0-4ml-pen-step6 (Humira 19)
Instructional illustration showing Step 6 for HUMIRA (Adalimumab) KIT administration. It demonstrates proper injection angles of 90 degrees into either the abdomen or thigh, with a visual of the injection site areas highlighted on a simplified human figure.*
FDA Label Image

Title: Humira Mai Ifu Resize1 Step7 (Humira 1a)

Title: Humira Mai Ifu Resize1 Step7 (Humira 1a)
An instructional diagram illustrating Step 7 of a process, showing a hand pressing down on an injection device with a timer indicating 10 seconds and a 'click' sound. A close-up inset highlights an indicator on the device displaying an orange and gray window.*
FDA Label Image

Title: Humira Mai Ifu Resize1 Step8 (Humira 1b)

Title: Humira Mai Ifu Resize1 Step8 (Humira 1b)
An instructional illustration labeled 'STEP 8' showing a person pulling off a red cap or cover from a syringe or similar device, with a downward arrow indicating the next step.*
FDA Label Image

Title: Ifu-40mg0-4ml-pen-step9 (Humira 1c)

Title: Ifu-40mg0-4ml-pen-step9 (Humira 1c)
An instructional illustration showing a hand holding a prefilled syringe above a sharps disposal container labeled as Step 9 in a sequence. This image appears to be part of usage or disposal instructions included in a kit for self-administration of medication.*
FDA Label Image

Title: Humira Mai Ifu Resize1 Calendar (Humira 1d)

FDA Label Image

Title: Humira Mai Ifu Abbvie Logo (Humira 1e)

FDA Label Image

Title: Step1-80mg-ifu (Humira 1f)

Title: Step1-80mg-ifu (Humira 1f)
An instructional diagram labeled Step 1 showing a hand reaching to take a gray rectangular item from a refrigerator shelf. The illustration emphasizes the first step in handling or preparing the product.*
FDA Label Image

Title: 80mg-mai-ifu-step4 (Humira 20)

Title: 80mg-mai-ifu-step4 (Humira 20)
Illustration showing Step 4 in the use of a medication pen device, depicting a hand holding the pen with a close-up inset highlighting part of the device mechanism, likely indicating where to press or check. The illustration includes a red arrow pointing downward, suggesting the next action to be taken.*
FDA Label Image

Title: Ifu-80mg-0-8ml-pen-step6 (Humira 21)

Title: Ifu-80mg-0-8ml-pen-step6 (Humira 21)
An instructional diagram showing step 6 of an injection process for HUMIRA (adalimumab). It illustrates injecting at a 90-degree angle into the abdomen or thigh, with accompanying directional arrows and a close-up of the injection site.*
FDA Label Image

Title: 80mg-mai-ifu-step7-arrow (Humira 22)

Title: 80mg-mai-ifu-step7-arrow (Humira 22)
An instructional illustration showing Step 7 of a process, indicating to hold and wait for 15 seconds until a 'click' sound is heard. It shows a close-up of a device window with a yellow indicator, likely confirming correct usage or completion.*
FDA Label Image

Title: 80mg-mai-ifu-logo (Humira 23)

FDA Label Image

Title: Syringe Image (Humira 24)

Title: Syringe Image (Humira 24)
An instructional diagram illustrating the parts of a syringe device, showing a pink plunger rod at the top, a finger grip in the middle, and a needle cover at the bottom.*
FDA Label Image

Title: Syringe Hand Holding (Humira 25)

Title: Syringe Hand Holding (Humira 25)
An illustration showing a hand holding a syringe with a protective cap partially removed, demonstrating the preparation or usage step of the HUMIRA (Adalimumab) KIT.*
FDA Label Image

Title: Fig-d-ifu-three-syringes (Humira 26)

Title: Fig-d-ifu-three-syringes (Humira 26)
Illustration showing three prefilled syringes of HUMIRA (Adalimumab) in different dosages: 40 mg with 0.8 mL volume, 20 mg with 0.4 mL volume, and 10 mg with 0.2 mL volume. Each syringe features a red plunger and clear barrel with volume markings.*
FDA Label Image

Title: Needle Cover Removal (Humira 27)

Title: Needle Cover Removal (Humira 27)
Instructional illustration showing a person holding a syringe in one hand and removing or attaching a small cap or component from the syringe using the other hand. Arrows indicate the direction of motion for the component.*
FDA Label Image

Title: Syringe Air Out (Humira 28)

Title: Syringe Air Out (Humira 28)
An instructional illustration showing a person's hands preparing a syringe, with one hand holding the syringe body and the other hand adjusting the plunger or cap. The image likely depicts a step in administering or preparing the medication HUMIRA (adalimumab) kit.*
FDA Label Image

Title: Syringe Hold Like Pencil (Humira 29)

Title: Syringe Hold Like Pencil (Humira 29)
An instructional illustration showing a hand holding a syringe with a needle attached and the plunger partially pressed. The hand grips the syringe by the barrel with the thumb on the plunger, demonstrating the typical positioning for administration.*
FDA Label Image

Title: Syringe Injection Angle (Humira 2a)

Title: Syringe Injection Angle (Humira 2a)
An instructional diagram showing a hand holding a syringe or injector device at a 45-degree angle aimed at the skin of a person's outer thigh area, demonstrating the proper angle for subcutaneous injection.*
FDA Label Image

Title: Syringe Injection Site Pressure (Humira 2b)

Title: Syringe Injection Site Pressure (Humira 2b)
An illustration showing a hand holding a circular pad, positioned near the lower leg or ankle of a person. The image appears instructional, likely demonstrating application of a pad or preparation of the skin area for treatment.*
FDA Label Image

Title: Ifu-single-dose-pfs-figk-sharps (Humira 2c)

Title: Ifu-single-dose-pfs-figk-sharps (Humira 2c)
An instructional illustration showing a hand disposing of a needle or syringe into a sharps disposal container. The image depicts the correct way to safely discard the needle by inserting it into the container opening, guided by a downward arrow.*
FDA Label Image

Title: Fig-a-exploded-pfs (Humira 2d)

Title: Fig-a-exploded-pfs (Humira 2d)
An instructional illustration labeled 'Figure A: HUMIRA Single-Dose Prefilled Syringe' showing the components of the syringe, including the plunger, finger grip, and needle cover, for the HUMIRA (adalimumab) injection kit by A-S Medication Solutions.*
FDA Label Image

Title: Ifu-single-dpse-pfs-step2 (Humira 2e)

Title: Ifu-single-dpse-pfs-step2 (Humira 2e)
Instructional illustration labeled 'STEP 2' showing a hand sanitizer dispensing on hands next to a disposal container, a test strip package, and a small metallic item, likely depicting a step in a medication administration or kit usage process.*
FDA Label Image

Title: Syringe-pms-step3 (Humira 2f)

Title: Syringe-pms-step3 (Humira 2f)
An instructional diagram showing Step 3 for injection site selection, highlighting the injectible areas on a human body silhouette, including front and side views of the abdomen and thighs. The diagram emphasizes where to administer the injection, labeled as 'Injectable Areas.'*
FDA Label Image

Title: Step4-pfs-ifu (Humira 30)

Title: Step4-pfs-ifu (Humira 30)
An instructional illustration showing Step 4 of a procedure involving injection preparation. It depicts one hand holding a syringe and the other hand adjusting or attaching a component to the syringe, likely part of a medication administration kit.*
FDA Label Image

Title: Syringe-pms-step5 (Humira 31)

Title: Syringe-pms-step5 (Humira 31)
An instructional illustration labeled Step 5 showing a hand holding a syringe being filled with liquid from a vial. The image is part of a step-by-step guide for preparing an injection.*
FDA Label Image

Title: Syringe-pms-step6 (Humira 32)

Title: Syringe-pms-step6 (Humira 32)
An instructional diagram labeled as step 6 showing a hand holding a syringe preparing to inject or withdraw medication from a vial. The close-up emphasizes needle placement and injection technique, part of a multi-step medication administration process.*
FDA Label Image

Title: New-step-7-syringes (Humira 33)

Title: New-step-7-syringes (Humira 33)
An instructional illustration showing step 7 for an injection process. It depicts a hand methodically positioning a syringe to inject into either the abdomen or thigh area, with the words 'ABDOMEN OR THIGH' highlighted in red. The image uses simple graphics with guiding arrows to emphasize proper injection site placement.*
FDA Label Image

Title: Step8-ifu-pfs (Humira 34)

Title: Step8-ifu-pfs (Humira 34)
Instructional illustration labeled Step 8 showing a hand holding a small injector device near the abdomen of a person wearing light-colored pants, indicating preparation for an injection as part of a usage guide for HUMIRA (Adalimumab) kit.*
FDA Label Image

Title: Ifu-single-dose-pfs-step9 (Humira 35)

Title: Ifu-single-dose-pfs-step9 (Humira 35)
An instructional illustration labeled 'STEP 9' showing a hand inserting a used syringe into a sharps disposal container, demonstrating safe disposal of the injection device.*
FDA Label Image

Title: Syringe-ifu-pms-abbvie-logo (Humira 36)

FDA Label Image

Label Image (Lbl500904487)

Label Image (Lbl500904487)
Label for HUMIRA 40 mg/0.8 mL single-use prefilled pen kit by A-S Medication Solutions. The label states contents include two prefilled pens, each with 40 mg adalimumab at 0.8 mL. Storage instructions specify refrigeration at 36 to 46 degrees Fahrenheit with protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.